Split History
ETFs Holding ZGNX »    ZGNX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Zogenix is a pharmaceutical company developing and commercializing transformative central nervous system (CNS) therapies for people living with CNS disorders and medical conditions. Co. is focused on developing and commercializing CNS therapies to address rare, or orphan childhood-onset epilepsy disorders. Co. owns and controls worldwide development and commercialization rights to Fintepla/ZX008, its primary product candidate. Fintepla is low-dose fenfluramine under development for the treatment of seizures associated with two rare and catastrophic forms of childhood-onset epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. According to our ZGNX split history records, Zogenix has had 1 split.
ZGNX split history picture
Zogenix (ZGNX) has 1 split in our ZGNX split history database. The split for ZGNX took place on July 01, 2015. This was a 1 for 8 reverse split, meaning for each 8 shares of ZGNX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.

When a company such as Zogenix conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ZGNX split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zogenix shares, starting with a $10,000 purchase of ZGNX, presented on a split-history-adjusted basis factoring in the complete ZGNX split history. ZGNX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/23/2010
End date: 05/22/2020
Start price/share: $31.84
End price/share: $29.98
Dividends collected/share: $0.00
Total return: -5.84%
Average Annual Total Return: -0.63%
Starting investment: $10,000.00
Ending investment: $9,417.36
Years: 9.50
Date Ratio
07/01/20151 for 8
ZGNX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ZLCS Split History
ZSAN Split History
A Split History
AAC Split History
ABC Split History
ABIO Split History
ABMD Split History
ABT Split History
ABV Split History
ACER Split History

Also explore: ZGNX shares outstanding history

Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
Cyclacel Pharmaceuticals, Inc. (CYCC)
Chesapeake Energy Corporation (CHK)
Direxion Daily Gold Miners Index Bull 3X Shares (NUGT)
Direxion Zacks MLP High Income Index Shares (ZMLP)
Direxion Daily Retail Bull 3X Shares (RETL)
Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT)
Direxion Daily Junior Gold Miners Index Bull 3X Shares (JNUG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ZGNX Insider Buying

ZGNX Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.